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Abstract
Background: Identifying a single disease as the underlying cause of death (UCOD) is an oversimplification of the
clinical-pathological process leading to death. The multiple causes of death (MCOD) approach examines any
mention of a disease in death certificates. Taking diabetes as an example, the study investigates: patterns of death
certification, differences in mortality figures based on the UCOD and on MCOD, factors associated to the mention
of diabetes in death certificates, and potential of MCOD in the analysis of the association between chronic diseases.
Methods: The whole mortality archive of the Veneto Region-Italy was extracted from 2008 to 2010. Mortality rates
and proportional mortality were computed for diabetes as the UCOD and as MCOD. The position of the death
certificate where diabetes was mentioned was analyzed. Conditional logistic regression was applied with chronic
liver diseases (CLD) as the outcome and diabetes as the exposure variable. A subset of 19,605 death certificates of
known diabetic patients (identified from the archive of exemptions from medical charges) was analyzed, with
mention of diabetes as the outcome and characteristics of subjects as well as other diseases reported in the
certificate as predictors.
Results: In the whole mortality archive, diabetes was mentioned in 12.3 % of death certificates, and selected as the
UCOD in 2.9 %. The death rate for diabetes as the UCOD was 26.8 × 105 against 112.6 × 105 for MCOD; the UCOD/
MCOD ratio was higher in males. The major inconsistencies of certification were entering multiple diseases per line
and reporting diabetes as a consequence of circulatory diseases. At logistic regression the mention of diabetes was
associated with the mention of CLD (mainly non-alcohol non-viral CLD). In the subset of known diabetic subjects,
diabetes was reported in 52.1 %, and selected as the UCOD in 13.4 %. The probability of reporting diabetes was
higher with coexisting circulatory diseases and renal failure and with long duration of diabetes, whereas it was
lower in the presence of a neoplasm.
Conclusions: The use of MCOD makes the analysis of mortality data more complex, but conveys more information
than usual UCOD analyses.
Introduction
Cause-specific mortality data are of paramount import-
ance to describe the health profile of a population, to set
priorities for health policy makers, and can be used to
evaluate the impact of preventive interventions. More-
over, cause-specific mortality represents a commonly
adopted end-point for epidemiologic studies and clinical
trials, and constitutes an essential information source to
build disease registries.
Usually, reported mortality data are limited to a single
cause of death, the underlying cause of death (UCOD),
which is selected from all diseases mentioned in the
death certificate according to international coding rules.
An additional approach is represented by the analysis of
all conditions reported in the certificate (multiple causes
of death – MCOD), to assess any mention of a disease
irrespective of its selection as the UCOD.
The adoption of MCOD analyses is necessary to
capture the multiple diseases that can lead to chronic
disease mortality, such as diabetes-related mortality [1, 2].
Diabetes is associated with several conditions result-
ing in an increased risk of death, mainly cardiovascular
* Correspondence: ugo.fedeli@regione.veneto.it
1Epidemiological Department, Veneto Region, Passaggio Gaudenzio 1,
Padova (PD) 35131, Italy
Full list of author information is available at the end of the article
© 2015 Fedeli et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Fedeli et al. Population Health Metrics  (2015) 13:21 
DOI 10.1186/s12963-015-0056-y
disorders, renal failure, and infectious diseases; further-
more, recently the association has emerged between dia-
betes and mortality from various forms of cancer [3, 4],
and from chronic liver disease (CLD) [5].
Important issues associated to certification practices
arise when dealing with diabetes-related mortality. The
first is the mention of diabetes on the death certificate:
although diabetes might not be reported because it really
did not contribute to death, previous studies found that
patients’ demographics, place of death, role of the certi-
fying physician, duration and treatment of diabetes, and
associated diseases influenced the probability of mention
of diabetes [6–11]. However, such studies were limited
to the US and UK, and were mainly carried out on small
samples of known diabetic subjects. Another problem is
placement of diabetes within the death certificates: it
heavily influences the probability of its selection as the
UCOD, and has been demonstrated to largely vary by
country [12]. MCOD data allow problems to be identi-
fied in the process of recording and elaborating informa-
tion on death certificates [13], and are fundamental to
elucidating heterogeneity between countries in the selec-
tion of chronic diseases, including diabetes, as the
UCOD [14, 15]. Indeed, mortality rates from diabetes,
judged only from the UCOD, can fluctuate over time
due to trends in certification practices; since MCOD
provide the most consistent data on time trends [16],
both MCOD and UCOD mortality rates should be ex-
amined to properly interpret changes in cause-specific
mortality [17, 18].
Lastly, MCOD can be analyzed to explore associations
between different diseases leading to death; however
many intricacies arise when associations found between
conditions mentioned in the certificate are assumed as
causal relationships at the population level [19].
The present study explores the limits and potential of
MCOD analysis in the assessment of the mortality bur-
den from diabetes in northeastern Italy, with the four
following specific aims:
1. to examine patterns of the mention of diabetes in
different sections of the death certificate, and the
associated probability of selection of diabetes as
the UCOD;
2. to compute mortality rates and proportional
mortality for diabetes, comparing figures based on
the UCOD and on MCOD;
3. to measure the rate and test factors associated to
the mention of diabetes in a subset of death
certificates of decedents from a cohort of known
diabetic subjects;
4. to assess the potential of MCOD data in the analysis
of associations between different diseases reported in
the certificate, even when the knowledge about such
relationship is still limited within the medical
community. As an example, results on the
association between diabetes and CLD in the whole
regional mortality archive were compared with those
of a study on mortality from CLD in a cohort of
diabetic subjects [5].
Methods
The death certificate and the selection of the UCOD
The certifying physician is required to report those con-
ditions involved in the causal chain of events leading to
death in Part I of the death certificate, and other signi-
ficant conditions contributing to death in Part II. A
proper certification in Part I (constituted by three or
four lines, according to country and time period) would
show a causal sequence from the immediate cause of
death, to intermediate cause(s), to a single underlying
cause of death, defined as the disease or injury which
initiated the train of morbid events leading directly to
death [17]. However, due to different types of inconsist-
encies in the certification (multiple diseases reported in
the line reserved to the underlying cause, incorrect
causal sequences), standard mortality statistics are based
on internationally adopted algorithms which identify the
UCOD from all the conditions reported in the certifi-
cate. The UCOD generally corresponds to the under-
lying cause stated by the certifier, but could also be
another disease reported in Part I or Part II, or a derived
condition [13].
The above algorithms are applied in an increasing
number of countries by means of the Automated Classifi-
cation of Medical Entities (ACME), which is a computer
program developed by the National Center for Health
Statistics to standardize assignment of the underlying
cause. ACME has become an international standard, and
many countries use the ACME decision tables as the basis
for their own systems [20].
Specific guidelines on death certification recommend-
ing placement of diabetes in Part I or II of the certifi-
cates are lacking. According to existing coding rules,
diabetes is selected as the UCOD when reported as a
cause if ischemic heart diseases or cerebrovascular dis-
eases in Part I of the certificate [3, 21]. When diabetes is
selected as the UCOD, the fourth character of diagnosis
codes should detail associated complications, such as
cardiovascular diseases and renal failure; however, owing
also to ambiguity of coding rules, most certificates are
coded to “diabetes without complications” [3].
The setting of the study
The Veneto region (northeastern Italy), has about 4.9
million inhabitants. Life expectancy is slightly higher
than national figures, about 80 and 85 years in males
and females, respectively. The main causes of mortality
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are represented by circulatory diseases and cancers [5].
The prevalence of self-reported diabetes is lower than
overall Italian figures, but is rapidly increasing over time
and is now approaching 5 % [22].
A copy of death certificates of each resident in the
Veneto region is routinely transmitted to the Regional
Epidemiology Department for coding of the causes of
death according to the International Classification of
Diseases, 10th Edition (ICD-10). Since 2008 the regional
mortality database includes not only the UCOD, but
all the diseases mentioned in the certificate, and the
selection of the UCOD is performed using the ACME
software.
Analysis of diabetes-related mortality
ICD-10 codes for diabetes (E10-E14) were searched for
in any position of the death certificates of the whole
mortality archive through the period 2008 to 2010 in
order to retrieve all diabetes-related deaths. According
to the Part and line where diabetes was placed by the
certifier on the death certificate, diabetes-related deaths
were classified according to the following mutually ex-
clusive categories: diabetes reported in the line reserved
for the underlying cause, alone or in combination with
other diseases; diabetes not chosen by the certifier as the
underlying cause, but mentioned in another line of Part I;
and diabetes not mentioned in part I, but only in Part II of
the certificate. In each case, the proportion of deaths with
diabetes selected as the UCOD by the ACME software
was determined.
Age- and gender-specific mortality rates and pro-
portional mortality were computed both for diabetes
selected as the UCOD by ACME, and for deaths with
any mention of the disease in the certificate. Population
figures from the National Institute for Statistics [23]
were the denominator of mortality rates. The ratio of
mortality rates with diabetes mentioned and with diabetes
selected (MCOD/UCOD) was computed.
Mention of diabetes in death certificates of known
diabetic subjects
Prevalence and determinants of mentioning diabetes
were analyzed in a subset of death certificates of known
diabetic subjects. Upon certification from a specialist, in
Italy subjects with diabetes receive disease-specific care
without any contribution to the costs: these patients are
listed in a regional archive of exemptions from medical
charges. This archive is estimated to include about
80 % of subjects identified as diabetic by multiple data
sources, and can be used for the identification of a large
cohort of diabetic patients; details have been previously
published [5]. Briefly, records from 173,260 patients ex-
empt from medical charges due to diabetes and alive on
December 31, 2007 were linked to the mortality archive
until December 31, 2010. The record-linkage was per-
formed on previously anonymized records, without any
possibility of identification of individuals.
The outcome dichotomous variable was mention of
diabetes in the death certificate. Since it represented a
common outcome in the study subjects, to estimate rela-
tive risks (RR) with 95 % Confidence Intervals (CI), in-
stead of standard logistic regression, Poisson regression
with a robust error variance was adopted both at univar-
iate and multivariate analysis [24]. The explanatory vari-
ables retrieved from mortality records were gender, age
at death, place of death, and mention on the certificate
of selected diseases: hypertensive diseases (ICD-10 codes
I10-I15), ischemic heart diseases (I20-I25), cerebrovascu-
lar diseases (I60-I69), neoplasms (C00-D48), renal failure
(N17-N19), diseases of the respiratory system (J00-J99),
and diseases of the digestive system (K00-K93). Further-
more, records of exemption from medical charges in-
cluded the date of diabetes registration in the archive.
This date could follow the diagnosis by several years, but
allowed for the identification of a sub-cohort of patients
(those registered before 2001) who definitely had a dur-
ation of diabetes of at least seven years prior to death.
All the above study variables were included in the multi-
variate analysis.
Association between diabetes and CLD in the death
certificate
In the whole regional mortality archive, the association
between diabetes and CLD was investigated as an ex-
ample of the analysis of associations between chronic
diseases mentioned in the certificate. Analyses were car-
ried out on subjects aged 30–89 years, and CLD-related
deaths were identified by codes K70, K73, K74 in any
position of the death certificate. CLDs were further classi-
fied as related to viral hepatitis infection (codes B15-B19),
to alcohol (codes for alcoholic liver diseases and for men-
tal and behavioral disorders due to use of alcohol, K70
and F10), or with non-viral non-alcohol related etiology
(NVNA-CLD, in the absence of the above codes).
To test the association between diabetes and CLD, any
mention in the death certificate of CLD was the out-
come variable, and any mention of diabetes was consid-
ered the exposure variable in a case–control analytic
approach. To investigate if such association could reflect
a real causal relationship at the population level, and to
limit known bias in MCOD analyses [19], three different
conditional logistic regression models were applied with
CLD-related deaths as cases. We chose conditional logistic
regression because we were not interested in model esti-
mates for variables other than mention of diabetes in the
death certificate, while taking into account stratification
variables. The simplest regression (Model 1) was stratified
by gender and age, with all non-CLD-related deaths as
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controls. In Model 2, controls were selected from condi-
tions thought to be less strongly associated with diabetes
than other disease categories: analysis was still stratified
by gender and age, but controls were restricted to dece-
dents from diseases of the respiratory system. Lastly, in
order to take into account common opinions among phy-
sicians filling out the death certificate, Model 3 was strati-
fied by the main variables demonstrated to be associated
to the mention of diabetes in known diabetic subjects: age,
gender, place of death, mention of selected circulatory
diseases, and mention of neoplasms in the certificate.
Controls were all non-CLD-related deaths. The analyses
were repeated for all CLD, and for viral, alcoholic, and
NVNA-CLD.
Results were compared with published findings from
the above cohort of diabetic patients, where the same
age interval was selected, the same disease definitions
were adopted, and a higher mortality from CLD was
found with respect to the general population. Through
indirect standardization, standardized mortality ratios
(SMR) with regional mortality rates as reference were
significantly increased in diabetic patients and varied by
etiology of liver disease [5].
Results
Analysis of diabetes-related mortality in the whole
regional archive
Out of 132,511 deaths in the regional population in 2008
to 2010, diabetes was mentioned in 16,279 decedents
(12.3 %); among the latter, diabetes was selected as the
UCOD in 3,873 (2.9 % of overall deaths). The MCOD/
UCOD ratio was 4.2. Table 1 shows that in approximately
two-thirds of certificates, diabetes was mentioned only in
Part II. In these cases, its selection as the UCOD was
highly improbable, although it was still possible by the ap-
plication of selection rules (specifically, Rule 3) [14]. When
diabetes was reported in Part I on the underlying cause
line, a large proportion of certificates (37 %) also men-
tioned other diseases on the same line. However, diabetes
was selected as the UCOD in more than 90 % of certifi-
cates if reported alone or as the first entered condition on
the line corresponding to the underlying cause. Moreover,
diabetes was often selected as the UCOD when mentioned
in other lines of Part I. Among 1,845 death certificates
where diabetes was in other lines of Part I, the most fre-
quent diseases reported as the first entered condition on
the underlying cause line were: hypertensive (15 %), ische-
mic cardiac (19 %), cerebrovascular (9 %), and other circu-
latory diseases (13 %), and neoplasms (14 %, data not
shown). In these cases, diabetes was selected as the
UCOD in 68 % of certificates with a circulatory disease
and in 31 % of certificates with a neoplasm on the under-
lying cause line.
Figure 1 shows proportional mortality and Table 2
reports mortality rates by gender and age class. It can be
seen that both proportional mortality and mortality rates
from diabetes were higher among males in younger age
classes, but thereafter the increase with age was steeper
among females. Such a tendency was found both in
UCOD and MCOD analysis. The MCOD/UCOD ratio
peaked in the 65–84 years age class, and was slightly
higher in males (4.4) than in females (4.0).
Mention of diabetes in a sub-set of known diabetic
subjects
In the cohort of diabetic subjects, 19,605 deaths were
identified. Diabetes was reported in any position in
52.1 % of death certificates, and selected as the UCOD
in 13.4 %. The other main UCODs were circulatory dis-
eases (36.2 % of deaths in the cohort) and neoplasms
(28.3 %). Table 3 shows that diabetes was unlikely to be
reported when the UCOD was a neoplasm, irrespective
of the site of cancer. The mention of diabetes was higher
with specific circulatory diseases selected as the UCOD
(hypertensive, ischemic heart, or cerebrovascular dis-
eases), even though in a substantial proportion of such
deaths diabetes was not reported in any part of the cer-
tificate. At univariate analysis, the mention of diabetes
increased with age, among females, in decedents at
home, and in the sub-cohort with long disease duration;
furthermore it varied by reported co-existing diseases
(Table 4). At multivariate analysis, recording of diabetes
was not associated with age, whereas this it was strongly
increased when renal failure, hypertensive, ischemic
heart, and cerebrovascular diseases were reported, and
decreased in the presence of a neoplasm. Place of death,
Table 1 Selection of diabetes as the underlying cause of death,
by part of the death certificate where the disease was
























than first on the
underlying cause line
677 103 15
Part I, other lines 1,845 1,102 60
Part II 11,171 303 3
TOTAL 16,279 3,873 24
aUCOD: underlying cause of death
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Fig. 1 Proportional mortality by gender and age class from diabetes selected as the underlying cause of death (UCOD), or mentioned in any
position of the death certificate: Veneto region, 2008–2010
Table 2 Mortality rates from diabetes in the Veneto region (Italy), 2008–2010: diabetes selected as the underlying cause of death, or
as any mention in the death certificate (multiple causes of death)
Underlying cause of death Multiple causes of death Multiple/underlying cause ratio
n Rate × 105 n Rate × 105
Males
<45 10 0.3 34 0.9 3.4
45–54 45 4.3 132 12.5 2.9
55–64 182 21.0 736 84.9 4.0
65–74 428 61.2 1840 263.0 4.3
75–84 642 163.6 3121 795.2 4.9
85+ 421 433.9 1812 1867.6 4.3
Total 1728 24.5 7675 108.7 4.4
Females
<45 6 0.2 11 0.3 1.8
45–54 12 1.2 56 5.4 4.7
55–64 61 6.8 219 24.5 3.6
65–74 188 23.6 854 107.0 4.5
75–84 657 106.2 2869 463.6 4.4
85+ 1221 459.4 4595 1729.0 3.8
Total 2145 29.0 8604 116.4 4.0
Males + females
<45 16 0.2 45 0.6 2.8
45–54 57 2.7 188 9.0 3.3
55–64 243 13.8 955 54.2 3.9
65–74 616 41.1 2694 179.8 4.4
75–84 1299 128.5 5990 592.3 4.6
85+ 1642 452.6 6407 1766.1 3.9
Total 3873 26.8 16279 112.6 4.2
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duration of disease, and, to a lesser extent, gender were
still significantly associated with the mention of diabetes.
Association between diabetes and CLD by different
analytic approaches
Table 5 shows the association between diabetes and CLD
in the whole regional mortality archive. In all analyses, if
there was mention of CLD in the death certificate, the
likelihood of diabetes being mentioned increased, support-
ing a causal relationship between the diseases. However,
the strength of the association and differences by etiology
of CLD varied according to the type of analysis performed.
With respect to Model 1 (analysis stratified only by age
and gender), all risk estimates were higher in Model 2
(controls restricted to respiratory deaths) and in Model 3
(analysis stratified by strong determinants of diabetes
reporting in the certificate). Furthermore, in Model 2 and
in Model 3 NVNA-related CLD displayed a higher risk
with respect to CLD with viral or alcoholic etiology.
Discussion
The study provides a comprehensive picture of the use
of MCOD in investigating the mortality burden related
to a chronic disease. The first issue regards diabetes
reporting in death certificates of decedents affected by
the disease. Physicians may not record diabetes on the
death certificate because they could be unaware of the
disease in the patient, may not consider that diabetes
contributed to the patient’s death, or may not have listed
diabetes because of space constraints [7]. Physicians
completing death certificates mention only conditions
considered to be instrumental in causing death, not all
prevalent diseases at death [25]. According to a review,
the median proportion of diabetes reporting in any pos-
ition of the death certificate among decedents with
known diabetes was only 43 % [26]. The recording of
diabetes in US death certificates did not increase from
1986 to 1993, being less than 40 % among decedents
with a history of diabetes [6]. In the TRIAD study, 39 %
of diabetic subjects had the disease recorded; diabetes
was less frequently reported for all causes of death other
than cardiac diseases, especially cancer [7]. In the US,
the mention of diabetes was higher if the certifying phys-
ician was the primary care physician [8], or if the place
of death was the patient’s home [9]. In studies from the
UK, diabetes was mentioned in 42-43 % of death cer-
tificates of known diabetics, being associated with an
increased duration of diabetes and insulin treatment,
increasing age, female gender, low social class, and a
cardiovascular underlying cause of death [10, 11]. The
present findings show a higher proportion of diabetes
reporting (52 %) with respect to studies from the US or
the UK. A problem of over-designation of diabetes as a
cause of death exists if the certifying physician lists all
diseases affecting the decedent, without considering
their real role in causing the death. On the other hand,
the present data show that diabetes was not mentioned
in a substantial proportion of certificates where cardio-
vascular disorders such as ischemic heart diseases were
selected as the UCOD. Furthermore, the study confirms
that many variables are associated with the mention of
diabetes: patient’s gender, long duration of disease, cir-
cumstances of death (for subjects dying at home certifi-
cates are generally filled by the family doctor or by a
community health physician), and co-existing diseases
leading to death. Unfortunately, we did not have data to
test the role of diabetes treatment on the mention of the
disease (no treatment, only oral anti-diabetic drugs, in-
sulin). Moreover, we had no measure of the specificity of
diabetes reporting; according to the few studies avail-
able in the literature, specificity was 98 % in the Rancho
Bernardo study [9], and the positive predictive value was
99 % in a sample of death certificates in France [27].
The second major issue is the quality of cause-of-
death statements in certificates with mention of diabetes.
It is often difficult for the certifying physicians to decide
whether to report diabetes in Part I of the certificate,
which indicates that diabetes directly caused death, or in
Part II, which suggests that diabetes contributed to death
but was not part of the sequence of events directly lead-
ing to death [20]. As an example, Taiwanese physicians
were much more likely to report diabetes in Part I
(70 %) than their counterparts in Sweden (21 %) and in
the US (36 %) [12]. When diabetes is recorded in Part I,
Table 3 Underlying cause of death in 19,605 known diabetic
subjects, and proportion of death certificates with mention of
diabetes. Veneto region (Italy), 2008-2010




Diabetes (E10-E14) 2,623 100
All circulatory diseases (I00-I99) 7,096 52
Hypertensive diseases (I10-I15) 773 66
Ischemic heart diseases (I20-I25) 3,090 55
Cerebrovascular diseases (I60-I69) 1,540 51
All other circulatory diseases 1,693 42
All neoplasms (C00-D48) 5,556 34
Colon, rectum and anus (C18-C21) 549 33
Liver and intrahepatic bile ducts (C22) 641 35
Pancreas (C25) 600 34
Trachea, bronchus and lung (C33-C34) 1,034 33
All other neoplasms 2,732 34
Respiratory diseases (J00-J99) 1,008 48
Digestive diseases (K00-K93) 878 45
All other causes of death 2,444 45
Fedeli et al. Population Health Metrics  (2015) 13:21 Page 6 of 10
there are two major types of improperly filled cause-of-
death statements: reporting more diagnoses per line, and
incorrect causal sequence among the reported diagnoses,
usually resulting in an UCOD selected by the ACME
software different from the underlying cause chose by
the certifying physician. In previous studies, about three-
quarters of the incorrect causal sequences involved
incorrectly reporting other conditions as the cause of
diabetes, mainly hypertension and acute myocardial in-
farction. A less frequent anomaly was diabetes incor-
rectly reported as the cause of other diseases [15, 28]. In
our database, diabetes was most frequently mentioned in
Part II of the certificate. When diabetes was reported on
the line reserved for the underlying cause in Part I as
the only or the first reported condition, it was selected
as the UCOD in most cases. Based on ACME decision
tables, many diseases can be the consequence of dia-
betes, and rejected causal sequences starting with dia-
betes as the underlying cause were rare. The other types
of error were much more frequent: reporting multiple
diseases per line, and diabetes mentioned in other lines
of Part I as due to other diseases, mainly selected cir-
culatory diseases. In these latter cases, which can be
regarded as a major flaw of death certification practices,
diabetes was frequently selected as the UCOD. A main
issue is the lack of training of the certifying physician.
The development of electronic certification has been
proposed to facilitate the process with online expla-
nations, and to limit errors when completing the death
certificate [29]. However, due to the ageing population
(the median age at death in the Veneto region was
78 years in males and 85 in females) and the associated
Table 4 Factors associated with mention of diabetes in death certificates of 19,605 known diabetic subjects. Veneto region (Italy),
2008-2010
N Diabetes mentioned (%) RR (CI) unadjustedb RR (CI) adjustedc
Age
<45 49 43 0.76 (0.55 – 1.05) 0.96 (0.72 – 1.29)
45–54 251 43 0.75 ( 0.65 – 0.87) 0.95 (0.84 – 1.08)
55–64 1,395 46 0.82 (0.77 – 0.87) 1.00 (0.95 – 1.06)
65–74 4,008 47 0.83 (0.80 – 0.87) 0.97 (0.94 – 1.01)
75–84 7,568 52 0.92 (0.90 – 0.95) 1.00 (0.97 – 1.03)
85+ 6,334 57 1.00 1.00
Gender
Females 9,183 55 1.11 (1.08 – 1.14) 1.06 (1.03 – 1.09)
Males 10,422 50 1.00 1.00
Duration of disease
>7 years 10,660 57 1.24 (1.21 – 1.27) 1.17 (1.14 – 1.20)
<7 years 8,945 46 1.00 1.00
Place of death
Home 4,327 68 1.44 (1.40 – 1.48) 1.40 (1.37 – 1.44)
Other 15,278 47 1.00 1.00
Other diseases mentioned in the certificate
Specific circulatory mentioneda 10,488 67 1.93 (1.87 – 1.99) 1.76 (1.70 – 1.82)
Not mentioned 9,177 35 1.00 1.00
Renal failure mentioned 3,661 63 1.27 (1.23 – 1.30) 1.26 (1.23 – 1.30)
Not mentioned 15,944 50 1.00 1.00
Tumors mentioned 6,658 39 0.67 (0.65 – 0.69) 0.85 (0.83 – 0.88)
Not mentioned 12,947 59 1.00 1.00
Respiratory diseases mentioned 6,356 53 1.02 (0.99 – 1.05) 1.06 (1.03 – 1.09)
Not mentioned 13,249 52 1.00 1.00
Digestive diseases mentioned 3,043 47 0.90 (0.86 – 0.93) 1.10 (1.06 – 1.14)
Not mentioned 16,562 53 1.00 1.00
aHypertensive diseases, ischemic heart diseases, cerebrovascular diseases
bRisk Ratios with 95 % confidence intervals estimated by Poisson regression with a robust error variance
cRisk Ratios with 95 % confidence intervals adjusted for all the other variables reported in the Table, estimated by Poisson regression with a robust error variance
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increase in the incidence of multiple comorbid condi-
tions, there may be no simple etiologic chain leading to
the identification of a single underlying cause; instead,
death often results from a complex interaction between
multiple factors [17, 29].
Within this context, official mortality data for chronic
diseases should be provided based both on the UCOD
and on MCOD. Age-specific mortality rates based on
the UCOD were similar to those reported in the litera-
ture, but among older age classes, rates based on MCOD
tended to be higher than previous reports. The ratio
between diabetes reported as MCOD/UCOD displays
heterogeneity by country: 4.2 in our study, 2.6 in France,
4.2 in UK, 4.5 in Sweden, and 3.1 in the US [30]. Overall,
diabetes was mentioned as MCOD in a larger proportion
of overall deaths (12.3 %) than reported in other coun-
tries: 5.3 % in France in 2002 [30], 5.1 % in England in
1995–2010 [31], 10.6 % in Canada in 2004–2008 [32],
and 9 %, 10 %, 9 % in 2000–2001 in Sweden, Taiwan,
and the US, respectively [12]. This finding might be due
to more recent data and an older population analyzed in
the present study, and to a higher propensity to report
diabetes in death certificates of elderly subjects.
The last issue is the association between different dis-
eases mentioned in the death certificate. Different mea-
sures of association have been proposed in the literature
[33]. The simplest analysis would involve examining the
frequency with which two conditions are reported together;
estimation of Odds Ratios (OR) stratified by confounding
factors such as age is usually necessary [19]. We compared
results on the association between diabetes and CLD in
the regional mortality archive (Table 5) with those from
the cohort of subjects exempt from medical charge
[5]. In this cohort, mortality from all CLD was higher
than in the general population in both analyses re-
stricted to the UCOD (SMR = 2.55), and in MCOD
analysis (SMR = 2.55). Results remained unchanged if
analyses were restricted to diabetics with long disease
duration, confirming a role of diabetes in increasing
the mortality from CLD. In MCOD analyses, mortality
was higher for NVNA-CLD (SMR= 2.86) than for alco-
hol- (SMR= 2.25) or virus-related CLD (SMR= 2.17) [5],
a finding similar to Model 2 and 3 of the present results.
Redelings and colleagues have already reviewed pos-
sible bias affecting ORs estimated from mortality data
[19]. Any exposure that increases the likelihood that
someone will die also increases the likelihood of inclu-
sion in the study, generating a type of selection bias
termed Berkson’s bias. Furthermore, chronic conditions
are rarely reported in death certificates without multiple
associated diseases, increasing the likelihood of spurious
associations between them. Selection bias can be limited
by choosing controls who died from diseases unrelated
to the exposure [19]. However, since diabetes increases
the mortality risk from many causes, our first choice was
not to restrict the selection of controls (Model 1); an
alternative strategy was to select deaths from respiratory
diseases (Model 2). Another strong bias possibly acting
in our database was reporting bias due to common opin-
ions among physicians completing death certificates,
based on the biological plausibility of a connection be-
tween diseases [19]. In our study, the mention of dia-
betes was increased in the presence of renal failure and
selected circulatory diseases, and decreased by the pres-
ence of cancer (including liver cancer, often arising from
CLD). This latter observation could be extended to
many chronic diseases, since the overall prevalence of
reported comorbid conditions is usually lower in deaths
with an underlying neoplastic cause [34, 35]. A further
analytic strategy was therefore to stratify by major fac-
tors associated with diabetes reporting (Model 3); how-
ever, this could have led to overmatching bias [19].
Furthermore, we had no data on completeness of the
mention of CLD in mortality records. In view of all the
above, caution is needed in examining associations ob-
served between diseases in MCOD data, and multiple
analytic strategies, such those adopted in the present
study, should be explored to confirm results. The associ-
ation between diseases reported in the death certificate
depends on a complex interplay between different factors:
the real etiological relationship between the diseases,
current medical knowledge and beliefs, and certification
practices. Such analyses could be useful to generate
etiologic hypotheses to be assessed by other study de-
signs. In our experience, preliminary findings from
the MCOD archive showing the association between
Table 5 Multiple causes of death analyses: Odds Ratio for
mention of diabetes (vs. no mention) in certificates reporting
chronic liver diseases, estimated by three different models of
conditional logistic regression. Veneto region (Italy), 2008-2010
Model 1 Model 2 Model 3
OR (CI)b OR (CI)b OR (CI)b
All CLDa
(n = 4,563)
1.59 (1.47 – 1.73) 1.69 (1.49 – 1.91) 1.91 (1.76 – 2.08)
Virus-related
CLDa (n = 1,103)
1.40 (1.19 – 1.65) 1.49 (1.23 – 1.81) 1.82 (1.53 – 2.15)
Alcohol-related
CLDa (n = 1,206)
1.68 (1.44 – 1.96) 1.62 (1.32 – 2.00) 1.79 (1.52 – 2.10)
NVNA-related
CLDa (n = 2,350)
1.67 (1.50 – 1.86) 1.82 (1.57 – 2.11) 2.06 (1.84 – 2.30)
aCLD = chronic liver diseases; 96 CLD were classified as related to both alcohol
and viral hepatitis
bOdds ratio with 95 % Confidence Interval
Model 1: stratified by gender and age; controls = all non-CLD related deaths
Model 2: stratified by gender and age; controls = deaths with respiratory
diseases as the underlying cause
Model 3: stratified by gender, age, place of death, mention of specific
circulatory diseases, and mention of cancer; controls = all non-CLD related
deaths
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diabetes and CLD led us to perform the cohort mor-
tality study.
The present study has both strengths and limitations
in exploring the potential of MCOD analyses. Among
the strengths, the study was carried out on mortality
data coded according to ICD-10, with selection of the
UCOD carried out by the ACME software. To our
knowledge, this is the largest study investigating rate
and factors associated to diabetes reporting in death cer-
tificates. Moreover, findings on the association between
diseases mentioned in the certificate were compared
with results of a cohort study. Among the limitations,
we did not have a direct measure of the negative pre-
dictive value and the specificity of reporting diabetes in
death certificates. Lastly, as in other countries [1], over
half of all diabetes deaths reported the code E149 (un-
specified diabetes mellitus without mention of complica-
tions); therefore, examination of the breakdown of specific
diabetic codes was not performed. It is worth noting that
the selected UCOD is also often “diabetes without compli-
cation” when diseases such as renal failure are mentioned
in the certificate. In these circumstances analytic strategies
based on MCOD are essential to capture the real burden
of mortality from diabetic renal disease [36].
As a final remark, a paper published more than fifty
years ago stated that although mortality statistics were
not intended to give a comprehensive picture of disease
prevalence among decedents, data based on MCOD
were more informative than usual UCOD tabulations,
especially for chronic conditions such as diabetes. Fur-
thermore, some diseases, including liver cirrhosis, were
found to be reported in association with diabetes more
frequently than in overall deaths [37]. In spite of these
old observations, such analyses are applied in few coun-
tries, and the scientific literature on the potential and in-
tricacies of MCOD remains limited.
Conclusion
MCOD conveys much more information than usual
mortality statistics based only on the UCOD. MCOD
analyses not only allow more complete assessment of
the burden of mortality related to chronic diseases, but
are also useful to monitor patterns and inconsistencies
in cause of death certification. Furthermore, associations
between diseases reported in death certificates can be
explored with the aim to generate etiologic hypotheses
to be assessed by other study designs.
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